Eupraxia Pharmaceuticals, Inc. · TSX:EPRX
Eupraxia Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 66 institutions reported holding Eupraxia Pharmaceuticals, Inc., 37.6% of its shares. Largest: Beutel, Goodman & Co Ltd., Affinity Asset Advisors, LLC and Scotiabank. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Eupraxia Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | 3.63M | 5.5% | −38,601 | Aug 12, 2026 |
| Affinity Asset Advisors, LLC | 1.65M | 2.5% | +60,995 | Aug 13, 2026 |
| Scotiabank | 1.39M | 2.1% | −8,020 | Aug 13, 2026 |
| Balyasny Asset Management L.P. | 1.35M | 2.0% | +15 | Aug 14, 2026 |
| Vivo Capital, LLC | 1.35M | 2.0% | no change | Aug 14, 2026 |
| PFM Health Sciences, LP | 1.21M | 1.8% | +670K | Aug 14, 2026 |
| Great Point Partners LLC | 1.2M | 1.8% | no change | Aug 14, 2026 |
| Jupiter Topco LLC | 1.05M | 1.6% | first report | Aug 14, 2026 |
| Rubric Capital Management LP | 867K | 1.3% | +176K | Aug 14, 2026 |
| Ikarian Capital, LLC | 810K | 1.2% | −405K | Aug 14, 2026 |